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SUMMARY – Unicameral bone cysts (UBC) are benign bone tumor-like lesions. Mostly they are 
located in the metaphyseal-diaphyseal region of long bones in children and adolescents. The etiology 
of UBC is still unclear. There is no consensus about the protocol of UBC treatment. The aim of this 
study was to evaluate the effectiveness of three different techniques for the treatment of UBC. This 
study included 129 pediatric patients with UBC treated at University Children’s Hospital in Belgrade 
during the 8-year period. The mean follow up was 7.14 years. The following parameters were observed: 
gender, age, site, length of cyst, cyst index, cortical thickness, presentation of pathologic fracture, heal-
ing of cyst, treatment complications and length of hospitalization. These parameters were correlated to 
three treatment modalities, i.e. intracystic methylprednisolone acetate injection (group 1), curettage 
with bone grafting (group 2) and osteoinductive procedure using demineralized bone matrix (group 
3). We found statistically significant differences in healing of the cysts and length of hospital treat-
ment between groups 1 and 2, and between groups 2 and 3. In conclusion, complete healing of UBC 
can be achieved only using open surgery procedure. Intracystic methylprednisolone acetate instillation 
can be considered a good option for initial treatment of UBC.
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Introduction
Various diseases can cause local bone defects in pe-
diatric population. Despite the heterogeneous mecha-
nism of occurrence, bone cysts present a poorly biome-
chanical locus and it can lead to pathologic fracture1.
Unicameral bone cysts (UBC) are benign bone tu-
mors in children. They are located in the metaphysis-
diaphysis zone of long bones. The UBC are mostly 
asymptomatic and diagnosed incidentally. The etiology 
of UBC is still unclear; trauma, inflammation and ve-
nous obstruction of bones have been proposed2,3.
The aim of this study was to compare three differ-
ent methods of treatment of UBC, i.e. intracystic in-
jection of methylprednisolone acetate (MPA) (Sca-
glietti procedure), curettage with bone grafting (auto-
osteoplastic procedure) and osteoinductive procedure 
using demineralized bone matrix (DBM).
Patients and Methods
This retrospective study included 129 pediatric pa-
tients aged 8-17 and treated at University Children’s 
Hospital in Belgrade, Serbia, during 8-year period 
(from January 2007 to January 2014). Patients were 
divided into three groups according to the method of 
treatment, as follows: group 1 treated with intracystic 
MPA injection (according to Scaglietti procedure); 
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group 2 treated with curettage and bone grafting; and 
group 3 treated with osteoinductive procedure using 
DBM.
The inclusion criterion for participation in the 
study was pediatric patient below age 18 diagnosed 
with UBC. The study included all patients with or 
without a history of previous treatment or previous 
fracture. The exclusion criteria were malignant tumor 
presentation, bone marrow disease, chronic autoim-
mune disease with steroid use, and patients on chemo-
therapy or radiotherapy.
The following parameters were observed: gender 
(male/female), age (≤8 years and >8 years), site (long or 
short bone), cyst diameter (≤5 cm or >5 cm), cyst index 
(area of the cyst/diaphysis diameter), cortical thickness 
(≤2 mm and >2 mm), presentation of pathologic frac-
ture (yes or no), healing of the cyst (months), compli-
cations (yes or no), and length of hospital stay (days). 
All parameters were evaluated according to radiologi-
cal findings in anteroposterior and lateral views.
Patients treated with curettage and bone grafting 
and patients treated by osteoinductive procedure 
(groups 2 and 3) had histopathologic verification of 
UBC but those treated by steroid injection did not.
Clinical data were collected from patient clinical 
records, for which the respective informed consent was 
obtained. The χ2-test, Fisher exact test and regression 
analysis were used to test the correlation between 
those three groups of patients. The level of statistical 
significance was set at p<0.05.
Surgical techniques
Group 1: Steroid injection-Scaglietti method4
We used two 11-gauge aspiration needles to aspi-
rate and wash the cyst under x-ray control. After wash-
ing the cyst, we inserted 80-180 mg of MPA into the 
cyst (3 mg per cm3 of cyst). The procedure was per-
formed three times at three-month interval between 
the procedures.
Group 2: Curettage and bone grafting
We used standard approach according to the cyst 
location. The cortex above the cyst was opened with 
four to eight drill holes. Using a chisel, we connected 
the holes and removed bone cortex. After removing 
fluid from the cyst, the membrane of the cyst was cu-
retted using various curettes (straight and curved). Af-
ter curettage, we used autologous bone graft taken 
from the iliac crest to fill the cyst and improve healing. 
The specimen obtained from the cyst was sent for his-
topathologic analysis.
Group 3: Osteoinductive procedure  
using demineralized bone matrix
The standard approach to the cyst was used includ-
ing opening the bone cortex, evacuation of the fluid 
and curettage of the cyst. The specimen obtained from 
the cyst was sent for histopathologic analysis. DBM 
pellets were used to induce healing of the cyst. We 
used cortical sterile allograft tissue, cortical dust of 
250-420 mic (Implant Services, Cortically Sterile Al-
lograft Tissue, Osteotech Inc., New Jersey, USA).
Postoperative treatment and radiological follow up
Postoperative management varied according to the 
location and volume of the cyst, presence of fracture 
and method of treatment, ranging from simple dress-
ing, cast immobilization, non-weight bearing and ac-
tivity restriction.
Radiographs were obtained on day 1 after the sur-
gery, at three-month follow up, and then every six 
months. Healing of the cyst was followed up by use of 
the radiographic Neer and Cole four-grade rating sys-
tem5,6. According to this system, grade I is defined as 
complete obliteration of the cyst, grade II as bone fill-
ing but with the presence of some opaque areas, grade 
III as visible lucent and multi-locular areas, and grade 
IV as postoperative signs being unchanged5. Grades I 
and II were considered as cyst healing.
Limitations of the study were the lack of cyst anal-
ysis against previous methods of treatment and of 
complication analysis, and exclusion of patients treated 
by other methods of treatment (drainage procedures 
using Kirschner wires, titanium elastic nail or cannu-
lated screws).
Results
The study included 93 (72.1%) boys and 36 (27.9%) 
girls treated during 8-year period (from January 2006 
to January 2014). The mean age of study patients was 
11.07 (range, 7-17) years. The majority of our patients 
were aged >8 years (79.8%) and had their long bones 
affected (89.1%). The patients were divided into three 
groups according to treatment options, as follows: 65 
(50.4%) patients treated with intracystic MPA injec-
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tion (group 1); 40 (31%) patients treated with curet-
tage and autologous bone grafting (group 2); and 24 
(18.6%) patients treated with osteoinductive proce-
dure using DBM (group 3).
According to the method of treatment, statistical 
significance was found for the site of affection, length 
of the cyst, presentation of pathologic fracture before 
treatment initiation and complication rate (Table 1).
Also, we found statistically significant differences 
in cyst healing and length of hospital stay between the 
intracystic MPA injection group (group 1) and curet-
tage and autologous bone grafting group (group 2), as 
illustrated in Table 1. The same variables yielded sig-
nificant differences between the curettage and autolo-
gous bone grafting group (group 2) and osteoinductive 
procedure using DBM group (group 3).
Table 2 shows a statistically significant correlation 
between healing of the cyst and length of hospital stay 
according to treatment options. The length of hospital 
stay was shortest in patients treated by MPA injection 
Table 1. Descriptive parameters of study patients













Categorical variable n (%) n (%) n (%) n (%)
Age (yrs):
≤8 26 (20.2) 11 (16.9) 11 (27.5) 4 (16.7) 0.378>8 103 (79.8) 54 (83.1) 29 (72.5) 20 (83.3)
Gender:
Male 93 (72.1) 47 (72.3) 29 (72.5) 17 (70.8) 0.988Female 36 (27.9) 18 (27.7) 11 (27.5) 7 (29.2)
Bone type:
Long bone 115 (89.1) 65 (100.0) 28 (70.0) 22 (91.7) <0.001Short bone 14 (10.9) 0 (0.0) 12 (30.0) 2 (8.3)
Cyst length:
≤5 cm 123 (95.3) 64 (98.5) 40 (100.0) 19 (79.2) <0.001>5 cm 6 (4.7) 1 (1.5) 0 (0.0) 5 (20.8)
Cortical thickness: 
≤2 mm 46 (35.7) 23 (35.4) 10 (25.0) 13 (54.2) 0.062>2 mm 83 (64.3) 42 (64.6) 30 /75.0) 11 (48.8)
Presentation of pathologic fracture:
Yes 24 (18.6) 8 (12.3) 6 (15.0) 10 (41.7) 0.005No 105 (81.4) 57 (87.7) 34 (85.0) 14 (58.3)
Complications:
Yes 9 (7.0) 0 (0.0) 3 (7.5) 6 (25.0) <0.001No 120 (93.0) 65 (100.0) 37 (92.5) 18 (75.0)
Numerical variable Mean±SD Mean±SD Mean±SD Mean±SD
Cyst index 0.77±0.13 0.78±0.10a,b,c 0.70±0.15 0.85±0.11 <0.001
Cyst healing (months) 24.86±7.57 29.78±4.84a,b 20.22±4.85 19.25±8.66 <0.001
Length of hospital stay (days) 6.41±4.41 3.23±1.16a,b 9.40±2.98 9.92±5.67 <0.001
*p<0.05 (two-sided); asignificant differences between intracystic steroid injection group and curretage and bone 
grafting group; bsignificant differences between intracystic steroid injection group and osteoinductive procedure 
using demineralized bone matrix group; csignificant differences between curretage and bone grafting group and 
osteoinductive procedure using demineralized bone matrix group.
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Table 2. Regression analysis according to group type and independent variables
Study variable Type of treatment
β unstandardized coefficient (95% CI) p value Collinearity statistics
Age 0.15 (-0.08 to 0.38) 0.217 1.15
Gender -0.05 (-0.24 to 0.18) 0.659 1.02
Bone type -0.19 (-0.50 to 0.05) 0.197 1.48
Diameter of the cyst 0.56 (-0.43 to 1.36) 0.183 1.40
Cortical thickness 0.10 (-0.10 to 0.31) 0.340 1.55
Presentation of pathologic fracture -0.10 (-0.52 to 0.24) 0.652 1.75
Complications -0.23 (-0.72 to 0.39) 0.409 1.49
The cyst index 0.25 (-0.59 to 0.97) 0.509 1.36
Healing of the cyst -0.05 (-0.06 to -0.03) <0.001 1.59
Duration of hospitalization 0.07 (0.04 to 0.13) <0.001 1.85
R 0.78
R2 0.61
Overall p value <0.001
95% CI = 95% confidence interval
Fig. 1. Results of treatment using Scaglietti procedure (before treatment, 6 months  
and 12 months after treatment) (A, B, C).
Fig. 2. Results of treatment using curettage and bone grafting (before treatment, after surgery and 12-month 
follow up) (A, B, C).
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into the cyst (group 1), while the period of cyst healing 
was shortest in patients treated by osteoinductive pro-
cedure (group 3). However, the latter had the longest 
duration of hospital treatment. Considering correla-
tion coefficient (R-value), there was no correlation be-
tween independent values (R=0.78). Also, correlation 
coefficient (R2) explained that 61% of all study vari-
ables could correlate with treatment options, and over-
all p-value indicated statistical significance of the pa-
rameters observed (p<0.001) (Table 2).
Discussion
The etiology and pathogenesis of UBC remain un-
clear. The most common hypothesis includes increas-
ing intracystic pressure caused by venous obstruction 
in combination with the release of lytic enzymes 
(prostaglandin E2 and interleukin 1β) produced by the 
cyst membrane2,7,8.
Treatment options for UBC are various, from per-
cutaneous to open methods of treatment. Intracystic 
corticosteroid injections according to Scaglietti et al. 
reduce prostaglandin E2 production4. Canavese et al. 
point to the importance of cystic membrane destruc-
tion, which leads to healing of the cyst9. Sakamoto et 
al. report on the healing effect of cyst curettage10. Open 
curettage in combination with bone grafting is still 
widely used5,11. Also widely used is DBM injection to 
stimulate bone production, but this technique has no 
effect on the cyst membrane12-14. All these methods of 
treatment are associated with cyst recurrence, partial 
healing or healing with residual lesions6,15-19.
In our study, we compared three methods of treat-
ment, i.e. minimally invasive Scaglietti procedure 
(group 1), curettage and autologous bone grafting 
(group 2) and osteoinductive procedure using DBM 
(group 3). Group 1 (Scaglietti procedure) was associ-
ated with a minimal risk of intraoperative or periopera-
tive complications (no complications), short hospital 
stay (3.23 days) and treatment of small cysts (<5 cm 
long) of long bones. The mean time of cyst healing ac-
cording to Neer and Cole (grades I and II) for Sca-
glietti procedure was 29.78 months, which was statisti-
cally significantly different from osteoinductive proce-
dure using DBM (19.25 months). The majority of bone 
cysts with presentation of pathologic fractures were 
treated using DBM implantation procedure (41.7%), 
which was statistically significantly different from Sca-
glietti and bone grafting groups. Considering the 
length of hospital stay expressed in days, we found sta-
tistically significantly different results for the treatment 
options used in the study. In the group of patients un-
dergoing Scaglietti procedure (group 1), the mean hos-
pital stay was 3.23 days, as compared with surgically 
treated patients (groups 2 and 3), where the length of 
hospital stay was 9.40 and 9.92 days,  respectively.
Hou et al. compared four different techniques of 
treatment in 40 UBC patients, as follows: group 1 
treated with MPA injection and autogenous bone 
marrow, group 2 treated with open curettage and graft-
ing using DBM, group 3 treated with open curettage, 
DBM grafting and internal instrumentation, and 
group 4 treated with curettage, ethanol cauterization, 
disruption of the cystic margin, DBM insertion and 
placement of cannulated screw. Radiographically de-
termined healing was 33% in group 1, 66% in group 2, 
100% in group 3 and 92% in group 4. The rate of com-
plete healing after curettage and grafting was 76.1%. 
Expressed in time (months), healing took 23.4 months 
in group 1, 12.2 months in group 2, 6.6 months in 
Fig. 3. Results of treatment using osteoinductive 
procedure (before treatment and 12-month follow up)  
(A, B).
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group 3 and 3.7 months in group 415. Comparing the 
results of this study with ours we found similar final 
outcome concerning healing period in our group of 
patients treated by use of Scaglietti procedure (29.78 
months), but much longer healing period in patients 
treated by curettage and bone grafting (20.22 months) 
and those undergoing curettage and DBM implanta-
tion (19.25 months). However, compared to our study, 
limitations in the study by Hou et al.15 were a small 
number of participants (40 vs. 129 patients) and short 
follow up period (18-84 months vs. 30-240 months).
The study by Donaldson and Wright evaluated 
healing period in the treatment of UBC in 37 patients. 
The mean patient age was 17.2±3.2 years and they 
were followed up for 7.0±1.0 years. The authors com-
pared healing period and complication rate in patients 
treated with open curettage and bone grafting and pa-
tients treated using curettage, bone grafting and intra-
medullary fixation. Restoration was fast in both groups, 
i.e. within 3 months of treatment, but patients with 
intramedullary fixation completed functional recovery 
faster, especially in association to previous pathologic 
fractured bones. The complication rate was 21.6% 
(8/37) for all participants and they included mild bone 
deformities (7/37) and malunion (1/37)20.
Conclusion
This study compared the minimally invasive proce-
dure and open surgery using bone grafting or DBM. 
Open surgery procedure using curettage of intracystic 
membrane and implantation of bone graft or DBM 
were the most reliable procedures in the treatment of 
UBC. We believe that complete healing of UBC can 
only be achieved using open surgery, thus additionally 
preventing the possible risk of residual lesions and frac-
tures during skeletal maturation. The minimally invasive 
method using MPA intracystic instillation is associated 
with short hospital stay, less intra-hospital costs and 
complications but also has long healing  period corre-
lated to activity restriction and second  surgery. Thus, 
MPA intracystic instillation can be considered a good 
option for initial treatment of long bone UBC.
References
 1. Urakawa H, Tsukushi S, Hosono K, Sugiura H, Yamada K, Ya-
mada Y, et al. Clinical factors affecting pathological fracture 
and healing of unicameral bone cysts. BMC Musculoskelet 
Disord. 2014;15:159-67. http://dx.doi.org/10.1186/1471-24 
74-15-159
 2. Chigira M, Maehara S, Arita S, Udagawa E. The aetiology 
and treatment of simple bone cysts. J Bone Joint Surg Br. 
1983;65(5):633-7. http://dx.doi.org//10.1302/0301-620X.65 
B5.6643570
 3. Neer CS, Francis KC, Johnston AD, Kiernan HA Jr. Current 
concept on the treatment of solitary unicameral bone cyst. Clin 
Orthop Relat Res. 1973;97:40-51. http://dx.doi.org/10.1097 
/00003086-197311000-00008.
 4. Scaglietti O, Marchetti PG, Bartolozzi P. The effects of meth-
ylprednisolone acetate in the treatment of bone cysts. Results 
of three year follow-up. J Bone Joint Surg Br. 1979;61-B(2): 
200-4.
 5. Neer CS, Francis KC, Marcove RC, Lerz J, Carbonara PN. 
Treatment of unicameral bone cyst. A follow-up study of one 
hundred seventy-five cases. J Bone Joint Surg Am. 1966;48(4): 
731-45.
 6. Wright JG, Yandow S, Donaldson S, Marley L. A randomized 
clinical trial comparing intralesional bone marrow and steroid 
injections for simple bone cysts. J Bone Joint Surg Am. 
2008;90(4):722-30. http://dx.doi.org/10.2106/JBJS.G.00620.
 7. Jaffe H, Lichtenstein L. Solitary unicameral bone cyst, with 
emphasis on the roentgen picture, pathologic appearance and 
pathogenesis. Arch Surg. 1942;44:1001-25.
 8. Watanabe H, Arita S, Chigira M. Aetiology of a simple bone 
cyst. A case report. Int Orthop. 1994;18:16-9. http://dx.doi.
org/10.1007/bf00180172.
 9. Canavese F, Wright JG, Cole WG, Hopyan S. Unicameral bone 
cysts: comparison of percutaneous curettage, steroid, and autolo-
gous bone marrow injections. J Pediatr Orthop. 2011;31:50-5. 
http://dx.doi.org/10.1097/BPO.0b013e3181ff7510.
10. Sakamoto A, Matsuda S, Yoshida T, Iwamoto Y. Clinical out-
come following surgical intervention for a solitary bone cyst: 
emphasis on treatment by curettage and steroid injection. J Or-
thop Sci. 2010;15:553-9. http://dx.doi.org/10.1007/s00776-
010-1485-x.
11. Oppenheim WL, Galleno H. Operative treatment versus ste-
roid injection in the management of unicameral bone cysts. J 
Pediatr Orthop. 1984;4:1-7.
12. Rougraff BT, Kling TJ. Treatment of active unicameral bone 
cysts with percutaneous injection of demineralized bone matrix 
and autogenous bone marrow. J Bone Joint Surg Am. 2002; 
84-A:921-9. http://dx.doi.org/10.2106/00004623-200206000 
-00005.
13. Killian JT, Wilkinson L, White S, Brassard M. Treatment of 
unicameral bone cyst with demineralized bone matrix. J Pediatr 
Orthop. 1998;18:621-4.
14. Chang CH, Stanton RP, Glutting J. Unicameral bone cysts 
treated by injection of bone marrow or methylprednisolone. J 
Bone Joint Surg Br. 2002;84:407-12.
15. Hou HY, Wu K, Wang CT, Chang SM, Lin WH, Yang RS. 
Treatment of unicameral bone cyst: a comparative study of se-
lected techniques. J Bone Joint Surg Am. 2010;92:855-62. 
http://dx.doi.org/10.2106/JBJS.I.00607.
B. Bukva et al. Treatment of bone cysts
Acta Clin Croat, Vol. 58, No. 3, 2019 409
16. Cho HS, Oh JH, Kim HS, Kang HG, Lee SH. Unicameral 
bone cysts: a comparison of injection of steroid and grafting 
with autologous bone marrow. J Bone Joint Surg Br. 2007; 
89:222-6.
17. Hunt KJ, Bergeson A, Coffin CM, Randall RL. Percutaneous 
curettage and bone grafting for humeral simple bone cysts. Or-
thopedics. 2009;32(2):89.
18. Mik G, Arkader A, Manteghi A, Dormans JP. Results of a 
minimally invasive technique for treatment of unicameral bone 
cysts. Clin Orthop Relat Res. 2009;467:2949-54. http://dx.doi.
org/10.1007/s11999-009-1008-2.
19. Schreuder HW, Conrad EU 3rd, Bruckner JD, Howlett AT, So-
rensen LS. Treatment of simple bone cysts in children with 
curettage and cryosurgery. J Pediatr Orthop. 1997;17:814-20.
20. Donaldson S, Wright JG. Simple bone cysts: better with age? J 
Pediatr Orthop. 2015;35:108-14. http://dx.doi.org/10.1097/
BPO.0000000000000336.
Sažetak
LIJEČENJE JEDNOKOMORNIH KOŠTANIH CISTA KOD DJECE: KOMPARATIVNA STUDIJA
B. Bukva, G. Vrgoč, D. Abramović, S. Dučić, I. Brkić i T. Čengić
Solitarne koštane ciste (SKC) su dobroćudne koštane lezije slične tumorima. Najčešće su lokalizirane u metafizno-dija-
fiznoj regiji dugih kostiju djece i adolescenata. Etiologija SKC nije razjašnjena. Ne postoji konsenzus o protokolu liječenja 
SKC. Cilj studije bio je procijeniti učinkovitost tri različite tehnike liječenja SKC. Studija je obuhvatila 129 bolesnika liječe-
nih u Sveučilišnoj dječjoj bolnici u Beogradu tijekom 8 godina (2007.-2014.). Srednje razdoblje praćenja bilo je 7,14 (2,5-10) 
godina. Parametri za uključivanje bili su: spol, dob, lokacija ciste, veličina ciste, indeks ciste, debljina korteksa, patološka 
fraktura, cijeljenje ciste, komplikacije liječenja i trajanje hospitalizacije. Usporedili smo navedene parametre s tri različite 
tehnike liječenja: apliciranje metilprednisolon acetata (MPA) unutar ciste (skupina 1), kiretaža i umetanje koštanog presatka 
(skupina 2) i osteoinduktivni postupak upotrebom demineralizirane koštane međustanične tvari (DKM) (skupina 3). Utvr-
đena je statistički značajna razlika u cijeljenju cista i trajanju hospitalizacije između skupina 1 i 2 te između skupina 2 i 3. U 
zaključku, potpuno liječenje SKC može se jedino postići otvorenom kirurškom tehnikom i time spriječiti mogući rizik od 
zaostalih lezija i fraktura. Minimalno invazivna metoda aplikacijom MPA unutar ciste može se smatrati dobrom opcijom za 
početno liječenje SKC dugih kostiju.
Ključne riječi: Koštane ciste; Dijete; Injekcije, intralezijske; Koštana transplantacija; Koštani matriks
